DaVita Inc logo

DaVita Inc

3
4
NYSE:DVA (USA)  
$ 132.54 -0.201 (-0.15%) 12:45 PM EST
17.91
P/B:
11.15
Market Cap:
$ 11.57B
Enterprise V:
$ 22.30B
Volume:
90.92K
Avg Vol (2M):
731.40K
Also Trade In:
Volume:
90.92K
Avg Vol (2M):
731.40K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for DaVita Inc ( ) from 1995 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. DaVita stock (DVA) PE ratio as of Apr 25 2024 is 17.91. More Details

DaVita Inc (DVA) PE Ratio (TTM) Chart

To

DaVita Inc (DVA) PE Ratio (TTM) Historical Data

Total 1215
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
DaVita PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-25 17.9 2024-02-21 16.3
2024-04-24 17.9 2024-02-20 16.6
2024-04-23 18.1 2024-02-16 16.5
2024-04-22 17.9 2024-02-15 16.2
2024-04-19 17.3 2024-02-14 16.7
2024-04-18 17.0 2024-02-13 15.3
2024-04-17 17.3 2024-02-12 15.4
2024-04-16 17.5 2024-02-09 14.8
2024-04-15 17.6 2024-02-08 15.0
2024-04-12 17.6 2024-02-07 15.1
2024-04-11 17.8 2024-02-06 15.2
2024-04-10 17.9 2024-02-05 15.0
2024-04-09 18.1 2024-02-02 15.0
2024-04-08 18.1 2024-02-01 15.2
2024-04-05 18.1 2024-01-31 14.6
2024-04-04 18.0 2024-01-30 14.5
2024-04-03 18.3 2024-01-29 14.6
2024-04-02 18.3 2024-01-26 14.5
2024-04-01 18.6 2024-01-25 14.5
2024-03-28 18.7 2024-01-24 14.1
2024-03-27 18.5 2024-01-23 14.0
2024-03-26 18.3 2024-01-22 14.1
2024-03-25 18.2 2024-01-19 14.2
2024-03-22 18.1 2024-01-18 14.2
2024-03-21 18.4 2024-01-17 14.1
2024-03-20 18.8 2024-01-16 14.2
2024-03-19 18.7 2024-01-12 14.7
2024-03-18 18.5 2024-01-11 14.9
2024-03-15 18.5 2024-01-10 14.8
2024-03-14 18.4 2024-01-09 14.7
2024-03-13 18.7 2024-01-08 14.7
2024-03-12 18.8 2024-01-05 14.5
2024-03-11 18.4 2024-01-04 14.3
2024-03-08 18.3 2024-01-03 14.2
2024-03-07 18.1 2024-01-02 14.4
2024-03-06 17.8 2023-12-29 14.2
2024-03-05 18.2 2023-12-28 14.1
2024-03-04 17.0 2023-12-27 15.9
2024-03-01 17.1 2023-12-26 16.0
2024-02-29 17.2 2023-12-22 16.0
2024-02-28 17.2 2023-12-21 16.1
2024-02-27 17.2 2023-12-20 15.9
2024-02-26 16.9 2023-12-19 16.3
2024-02-23 16.9 2023-12-18 16.4
2024-02-22 16.6 2023-12-15 16.2

DaVita Inc (DVA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.